Lalam Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 04-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 04-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -33.02%
(FY 2022)
- Profit -121.27%
(FY 2022)
- Ebitda -62.43%
(FY 2022)
- Net Worth -411.52%
(FY 2022)
- Total Assets -80.67%
(FY 2022)
About Lalam Lifesciences
The Corporate was formerly known as Lalam Lifesciences Private Limited. The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Binod Maroti and Nirav Maroti serve as directors at the Company.
- CIN/LLPIN
U51909WB2017PTC219694
- Company No.
219694
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Mar 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Lalam Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Binod Maroti  | Director | 05-Apr-2021 | Current |
| Nirav Maroti | Director | 01-Mar-2017 | Current |
Financial Performance of Lalam Lifesciences.
Lalam Lifesciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 33.02% decrease. The company also saw a substantial fall in profitability, with a 121.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 411.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lalam Lifesciences?
In 2021, Lalam Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sun-Kwik Appliances Private LimitedActive 24 years 19 daysBinod Maroti and Nirav Maroti are mutual person
Greenfarm Machineries Private LimitedActive 17 years 6 monthsBinod Maroti and Nirav Maroti are mutual person
- Eminent Sales Private LimitedActive 23 years 4 months
Binod Maroti and Nirav Maroti are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Lalam Lifesciences?
Lalam Lifesciences has a workforce of 1 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lalam Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lalam Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
